Russian, Belarusian PM discuss progress and plans for Sputnik V COVID vaccine production

Russia and Belarus, on vember 5, discussed ongoing clinical trials of Russian Sputnik V coronavirus vaccine, Belarusian government informed. Russian PM Mikhail Mishustin and his Belarusian counterpart, Roman Golovchenko held a telephone conversation to discuss topical issues of tre, ecomic, energy, transport and logistics spheres. two leers ditionally also discussed progress of clinal trials and preparations for vaccine production in Belarus. 

statement by Belarusian government re, “ parties (Russia and Belarus) discussed topical issues of cooperation in tre, ecomic, energy, transport and logistics spheres. In dition, y exchanged information on progress of clinical trials of Sputnik V vaccine and preparations for its production in Republic of Belarus”. 

RE: Russia’s Sputnik V Vaccine To Be Tested On 100 Indian Volunteers During Its Phase-2 Trials

On Wednesday, press service of Belarusian President Alexander Lukashenko h anunced that Russian President Vlimir Putin h expressed for Lukashenko’s proposal to produce a vaccine against COVID-19 in Belarus, with use of Russian techlogy. 

Back in August, Russia h become first country in world to register a vaccine against coronavirus, dubbed Sputnik V. vaccine is developed by Gamaleya research institute. Sputnik V vaccine was ministered to volunteers in Belarus in October, as part of ongoing trails. 

RE: Mankind Pharma-RDIF Ink Pact For Marketing And Distribution Of Sputnik V Vaccine

Russia’s Sputnik V vaccine 

In a separate development earlier, Russian health minister Mikhail Murashko has informed that one in seven volunteers who have received a dose of indigeus COVID-19 vaccine have complained of side effects; including weakness, fever and muscle pain. He told a Russian daily that more than 300 people have alrey received Sputnik V vaccine as part of three-phase trial, ding that 14 per cent have complained about ir health. According to minister, side effects are predicted and usually disappear after a day or a maximum day and a half.

Meanwhile, results of Phase 1 and 2 trials of Russain vaccine show serious verse effects and a stable immune response in 100 per cent of participants, according to report published in Lancet medical journal. final clinical trials of Sputnik V COVID-19 vaccine are currently ongoing. As per reports, more than 55,000 people have applied to take part in post-registration trials, following clinical trials of Sputnik V vaccine involving 40,000 volunteers that are currently underway. first results of trials are expected to be published in vember 2020.

(With inputs from ANI) 

RE: COVID-19 Vaccine: DCGI Allows Dr Reddy's Lab To Conduct Trials Of Sputnik V

RE: UN Stresses On WHO Clearance For COVID-19 Vaccines, Russia's Sputnik V Included